John Parkinson

Researchers have found 6 inflammatory molecules in critically ill patients, which might be used as therapeutic targets in fighting COVID-19.

A group of scientists hypothesize these shots could protect young children from the novel virus.

A European study shows a small amount of hospitalized children and adolescents with COVID-19 require intensive care and is rarely fatal.

New research shows microorganisms on this part of the body may be able to diagnose chronic heart failure.

In a small randomized trial, Greek investigators found patients had improved time to clinical deterioration versus a control group.

Finch Therapeutics announced its investigational oral microbiome drug, CP101, reached a sustained clinical cure in its Phase 2 trial.

Company’s anti-infective agent sees setback related to COVID-19.

With the current COVID-19 outbreak, new data about Influenza mortality related to spectator sports should make the professional leagues and fans pause about attending games.

Compared to 2019, out-of-hospitalization cardiac arrest resuscitations saw a dramatic increase as well as differences in the types of patients experiencing these episodes.

A telephone survey confirms people are dealing with these issues and suggests it may be an early bellwether to providers and patients alike.

In a recent US survey, African American male participants knew more people infected with COVID-19, had greater knowledge disparities, and were exposed to the virus more than other groups.

the company announced it COVID-19 medication is looking to address viral replication and uncontrolled inflammatory response.

A modeling study from the UK reinforces how the transmission rates from infected people can be lowered using a variety of well-known strategies.

New study shows reduced deaths by one-third in ventilated patients, and one-fifth in patients receiving oxygen

In a modeling study, an estimated 1.7 billion people are at an increased risk of the virus, but a much smaller percentage would require hospitalization.

In a controlled environment, investigators found sunlight affected the decay rate of the virus.

During the spring COVID-19 outbreak, an examination of Swiss people in Geneva shows only a small amount of the population with IgG antibodies.

In a very small international study using the antiviral, 68% of hospitalized patients on ventilators or oxygen showed improvement.

As the lockdown ends, the NIAID director talks the continued need for social distancing, vaccines, and emerging therapies.

The antibacterial is efficacious in a majority of patients in a small study.

Baloxavir marboxil showed superiority over placebo and similar efficacy to oseltamir in reducing influenza symptoms.

Early administration of such therapies in this patient group not shown to help mortality rates.

An assessment of 21 pediatric cases leads France investigators to believe development is due to post-viral immunological reactions.